allergic to glp 1 Hypersensitivity glucagon‐like peptide‐1 receptor agonists: A case of delayed urticaria‐like rash to dulaglutide and literature review - Bianchi - 2024 - JEADV Clinical Practice Impact of GLP-1 Allergic Reactions

[DOI] [PMC free article] [PubMed] [Google Scholar] 81.Kasina S.V.S.K., Baradhi K.M

Structure Therapeutics is developing GSBR-1290, an oral small molecule GLP-1 agonist that could potentially address the manufacturing scalability challenges facing peptide-based injectablesthe company has noted its current manufacturing capacity could theoretically supply over 120 million patients [46]

12-14 A1C reductions of 0.4% to 0.9% were observed in studies of exenatide, with higher reductions achieved at the 10 mcg twice-daily dose

Because exosomes and many peptides are pro-growth, they can be risky in active cancer or where malignancy is suspected

doi: 10.1139/h2012-068

"We don't know where you're getting it from," she said